Pyxis Oncology
PYXS48
$1.69arrow_drop_up9.74%$0.14
Penny Stock
PYXS48
$1.69
arrow_drop_up9.74%| Key Stats | |
|---|---|
| Open | $1.54 |
| Prev. Close | $1.54 |
| EPS | -1.06 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $100.49M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 1.48 | 1.72 |
| 52 Week Range | 1.35 | 6.85 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -1.06 |
| Fundamentals | |
|---|---|
| Gross Profit | - |
| Payout Ratio | - |
| Industry average yield | 2.93% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
PYXS-
US Healthcare Sector-
US Market-
check_circle
PYXS / Market
PYXS exceeded the US Market which returned 1.43% over the last twenty four hours.check_circle
PYXS / Healthcare Sector
PYXS exceeded the US Healthcare sector which returned 3.54% over the last twenty four hours.Pyxis Oncology (PYXS) Statistics
Keep an eye on Pyxis Oncology
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Pyxis Oncology (PYXS) stock's performance compared to its sector and the market over the past year?
Over the past year, Pyxis Oncology (PYXS) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.21%, Pyxis Oncology has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 50.96%, it has fallen short of the market average. This comparison highlights Pyxis Oncology's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Pyxis Oncology (PYXS) stock?
The PE ratio for Pyxis Oncology (PYXS) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of Pyxis Oncology (PYXS) stock?
The Earnings Per Share (EPS) for Pyxis Oncology (PYXS), calculated on a diluted basis, is -$1.06. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Pyxis Oncology (PYXS) stock?
The operating margin for Pyxis Oncology (PYXS) is -398.68%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Pyxis Oncology (PYXS) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Pyxis Oncology (PYXS) is -$61.25M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Pyxis Oncology (PYXS) have?
Pyxis Oncology (PYXS) has a total debt of $20.54M. The net debt, which accounts for cash and cash equivalents against the total debt, is $8.48M.